BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8336822)

  • 1. Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice.
    Mjellem N; Lund A; Hole K
    Neuropharmacology; 1993 Jun; 32(6):591-5. PubMed ID: 8336822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different functions of spinal 5-HT1A and 5-HT2 receptor subtypes in modulating behaviour induced by excitatory amino acid receptor agonists in mice.
    Mjellem N; Lund A; Hole K
    Brain Res; 1993 Oct; 626(1-2):78-82. PubMed ID: 7506633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
    Alhaider AA; Wilcox GL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):378-85. PubMed ID: 7682614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats.
    Lund A; Mjellem-Jolly N; Hole K
    Neuropharmacology; 1992 Jan; 31(1):25-32. PubMed ID: 1531864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 5-HT1A and 5-HT1B receptors in spinal nociceptive transmission and in the modulation of NMDA induced behaviour.
    Mjellem N; Lund A; Eide PK; Størkson R; Tjølsen A
    Neuroreport; 1992 Dec; 3(12):1061-4. PubMed ID: 1337283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine response to clonidine and 8-OH-DPAT in rats following chronic administration of desipramine or sertraline.
    O'Donnell JM; Grealy M
    Br J Pharmacol; 1992 Apr; 105(4):863-8. PubMed ID: 1387021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists.
    Detke MJ; Wieland S; Lucki I
    Psychopharmacology (Berl); 1995 May; 119(1):47-54. PubMed ID: 7675949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.
    Li Q; Levy AD; Cabrera TM; Brownfield MS; Battaglia G; Van de Kar LD
    Brain Res; 1993 Dec; 630(1-2):148-56. PubMed ID: 8118681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons.
    Ahlers ST; Weissman BA; Barrett JE
    J Pharmacol Exp Ther; 1992 Feb; 260(2):474-81. PubMed ID: 1531359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different role of 5-HT1A and 5-HT2 receptors in spinal cord in the control of nociceptive responsiveness.
    Eide PK; Hole K
    Neuropharmacology; 1991 Jul; 30(7):727-31. PubMed ID: 1717872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of GABA release via NMDA and 5-HT1A receptors in guinea pig dentate gyrus.
    Matsuyama S; Nei K; Tanaka C
    Brain Res; 1997 Jun; 761(1):105-12. PubMed ID: 9247072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat.
    Przegaliński E; Ismaiel AM; Chojnacka-Wójcik E; Budziszewska B; Tatarczyńska E; Błaszczyńska E
    Neuropharmacology; 1990 Jun; 29(6):521-6. PubMed ID: 2143565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.
    Lund A; Mjellem N
    Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze.
    Moraes CL; Bertoglio LJ; Carobrez AP
    Behav Brain Res; 2008 Dec; 194(2):181-6. PubMed ID: 18675851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of RX 821002 at 5-HT1A-receptors in rabbit spinal cord in vivo.
    Ogilvie J; Clarke RW
    Br J Pharmacol; 1998 Mar; 123(6):1138-42. PubMed ID: 9559897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responsiveness of inbred strains of rats to antidepressants in the forced swimming test: are Wistar Kyoto rats an animal model of subsensitivity to antidepressants?
    Lahmame A; Armario A
    Psychopharmacology (Berl); 1996 Jan; 123(2):191-8. PubMed ID: 8741943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is NAN-190 an effective antagonist of the hypothermia and hyperglycemia induced by the 5-HT1A receptor agonist, 8-OH-DPAT?
    Wozniak KM; Durcan MJ; Linnoila M
    Eur J Pharmacol; 1991 Feb; 193(2):253-6. PubMed ID: 1828770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
    Gronier B
    Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.